.Pharmacolibrary.Drugs.N_NervousSystem.N05A_Antipsychotics.N05AD09_Fluanisone.Fluanisone .Pharmacolibrary.Drugs.N_NervousSystem.N05A_Antipsychotics.N05AD09_Fluanisone.Fluanisone| name: | Fluanisone |
| ATC code: | N05AD09 | route: | intramuscular |
| n-compartments | 2 |
Fluanisone is a typical antipsychotic from the butyrophenone group, structurally related to haloperidol. It was historically used in Europe for the treatment of schizophrenia, psychosis, and agitation, as well as a component of injectable veterinary sedatives (notably fluanisone/fentanyl combinations for small animals). It is not currently widely used or approved for use in humans today due to newer antipsychotics with improved safety profiles.
Estimated pharmacokinetic parameters based on limited data and analogy to other butyrophenone antipsychotics (such as haloperidol), for adult human subjects; no direct PK human studies are published.